抗焦虑药
乳酸
药理学
化学
医学
生物
生物化学
细菌
受体
遗传学
作者
Guyoung Kwon,Hyun Ji Kim,Se Jin Park,Hyung Eun Lee,Hyun Woo,Young Je Ahn,Qingtao Gao,Jae Hoon Cheong,Dae Sik Jang,Jong Hoon Ryu
出处
期刊:Life Sciences
[Elsevier]
日期:2014-02-25
卷期号:101 (1-2): 73-78
被引量:32
标识
DOI:10.1016/j.lfs.2014.02.011
摘要
Danshensu [3-(3,4-dihydroxyphenyl)-lactic acid], a phenylpropanoid compound isolated from Prunella vulgaris var. lilacina, is a well-known antioxidant. Although its antioxidant activity and cardioprotective effect have been reported, the pharmacological properties of danshensu in the central nervous system remain unclear. We investigated whether danshensu exerts anxiolytic-like activity in mice. We conducted monoamine oxidase A (MAO-A) inhibition assay on danshensu in vitro, and behavioral tests including the elevated plus-maze test (EPM), the hole-board test, the rotarod test and the open field test were employed. We found that danshensu significantly inhibited the activity of MAO-A in vitro. The administration of danshensu (3 or 10 mg/kg) produced a significant anxiolytic-like effect in the EPM and hole-board test. In addition, no changes in the spontaneous locomotor activity and no myorelaxant effects were observed compared to the control group; these effects were confirmed with the open field test and the rotarod test. Moreover, the anxiolytic-like properties of danshensu were antagonized by a dopamine D1 receptor antagonist (SCH 23390) but not by a 5-HT1A receptor antagonist (WAY 100635) or an α1-adrenergic receptor antagonist (prazosin). These results indicate that danshensu exerts its anxiolytic-like properties, in part, through dopaminergic neurotransmitter signaling.
科研通智能强力驱动
Strongly Powered by AbleSci AI